FRTX Projected Dividend Yield
Fresh Tracks Therapeutics Inc ( OTCBB : FRTX )Fresh Tracks Therapeutics is a clinical-stage pharmaceutical company focused on the development of prescription therapeutics for the treatment of debilitating skin diseases with a focus on its main asset for the treatment of hyperhidrosis. Co.'s investigational product candidate, sofpironium bromide, is a chemical entity that belongs to a class of medications called anticholinergics. Anticholinergics block the action of acetylcholine, a chemical that transmits signals within the nervous system that are responsible for a range of bodily functions, including activation of the sweat glands. Co. is developing sofpironium bromide in the U.S. for the treatment of primary axillary hyperhidrosis. 20 YEAR PERFORMANCE RESULTS |
FRTX Dividend History Detail FRTX Dividend News FRTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |